These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26536)

  • 1. Pharmacokinetic model of presystemic metabolism.
    Colburn WA; Gibaldi M
    Drug Metab Dispos; 1978; 6(2):193-6. PubMed ID: 26536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary: theoretical predictions of flow effects on intestinal and systemic availability in physiologically based pharmacokinetic intestine models: the traditional model, segregated flow model, and QGut model.
    Pang KS; Chow EC
    Drug Metab Dispos; 2012 Oct; 40(10):1869-77. PubMed ID: 22745334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of administration route and blood sampling site on the area under the curve. Assessment of gut wall, liver, and lung metabolism from a physiological model.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1983; 11(1):62-6. PubMed ID: 6132799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of absorption, intestinal and hepatic first pass effect in a chronic dog model.
    Lemaire M; Bodoky A; Heberer M; Niederberger W
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():132-5. PubMed ID: 1820867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic model to differentiate preabsorptive, gut epithelial, and hepatic first-pass metabolism.
    Colburn WA
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):407-15. PubMed ID: 512846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presystemic and systemic intestinal metabolism of fenoterol in the conscious rat.
    Koster AS; Hofman GA; Frankhuijzen-Sierevogel AC; Noordhoek J
    Drug Metab Dispos; 1985; 13(4):464-70. PubMed ID: 2863112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new physiologically based, segregated-flow model to explain route-dependent intestinal metabolism.
    Cong D; Doherty M; Pang KS
    Drug Metab Dispos; 2000 Feb; 28(2):224-35. PubMed ID: 10640522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of gastrointestinal absorption and metabolism.
    Zimmerman CL; Wen Y; Soria I; Pithavala YK
    Drug Metab Rev; 1997 Nov; 29(4):957-75. PubMed ID: 9421681
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis and prediction of absorption profile including hepatic first-pass metabolism of N-methyltyramine, a potent stimulant of gastrin release present in beer, after oral ingestion in rats by gastrointestinal-transit-absorption model.
    Kimura T; Iwasaki N; Yokoe JI; Haruta S; Yokoo Y; Ogawara KI; Higaki K
    Drug Metab Dispos; 2000 May; 28(5):577-81. PubMed ID: 10772638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the well-stirred model assess the intestinal first-pass effect well?
    Mizuma T; Tsuji A; Hayashi M
    J Pharm Pharmacol; 2004 Dec; 56(12):1597-9. PubMed ID: 15563767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The bioavailability of orally administered drugs with special regard to the liver as a filter for foreign matter].
    Raaflaub J
    Schweiz Med Wochenschr; 1980 Mar; 110(10):354-62. PubMed ID: 7394464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of intestinal availability of various drugs in the oral absorption process using portal vein-cannulated rats.
    Matsuda Y; Konno Y; Satsukawa M; Kobayashi T; Takimoto Y; Morisaki K; Yamashita S
    Drug Metab Dispos; 2012 Dec; 40(12):2231-8. PubMed ID: 22930277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [First-past Effect (author's transl)].
    Leopold G
    Arzneimittelforschung; 1977 Feb; 27(2A):241-9. PubMed ID: 577169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gut contents, intestinal wall, and liver on the first pass metabolism and absolute bioavailability of isotretinoin in the dog.
    Cotler S; Buggé CJ; Colburn WA
    Drug Metab Dispos; 1983; 11(5):458-62. PubMed ID: 6138231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating drug solubility in the gastrointestinal tract.
    Dressman JB; Vertzoni M; Goumas K; Reppas C
    Adv Drug Deliv Rev; 2007 Jul; 59(7):591-602. PubMed ID: 17599644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo O-de-ethylation of phenacetin in 3-methylcholanthrene-pretreated rats: gut wall and liver first-pass metabolism.
    Klippert PJ; Littel RJ; Noordhoek J
    J Pharmacol Exp Ther; 1983 Apr; 225(1):153-7. PubMed ID: 6834267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Side effects of drugs in the elderly. A review of various possible causes].
    van Bezooijen CF
    Tijdschr Gerontol Geriatr; 1985 Oct; 16(5):191-8. PubMed ID: 3909542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.